Raben David
Insider CIK 2034679 · PLRX Chief Medical Officer · BCAX Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2026-10-01 | 2026-10-02 | 575,000 | — | $0 | 575,000 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | M Exercise deriv | 2026-04-27 | 2026-04-28 | 5,500 | — | $0 | 41,913 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | M Exercise | 2026-04-27 | 2026-04-28 | 5,500 | $3.79 | $20.8K | 60,786 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | S Sale | 2026-04-27 | 2026-04-28 | 5,500 | $22.88 | $125.8K | 55,286 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | M Exercise deriv | 2026-03-25 | 2026-03-26 | 5,500 | — | $0 | 47,413 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | M Exercise | 2026-03-25 | 2026-03-26 | 5,500 | $3.79 | $20.8K | 60,786 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | S Sale | 2026-03-25 | 2026-03-26 | 5,500 | $18.95 | $104.2K | 55,286 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | M Exercise deriv | 2026-03-04 | 2026-03-05 | 16,300 | — | $0 | 52,913 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | S Sale | 2026-03-04 | 2026-03-05 | 16,300 | $18.52 | $301.9K | 55,286 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | M Exercise | 2026-03-04 | 2026-03-05 | 16,300 | $3.79 | $61.8K | 71,586 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | M Exercise deriv | 2026-03-03 | 2026-03-05 | 200 | — | $0 | 69,213 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | M Exercise | 2026-03-03 | 2026-03-05 | 200 | $3.79 | $758 | 55,486 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | S Sale | 2026-03-03 | 2026-03-05 | 200 | $18.45 | $3.7K | 55,286 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | A Award deriv | 2026-02-02 | 2026-02-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | M Exercise deriv | 2025-12-26 | 2025-12-29 | 19,789 | — | $0 | 98,987 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | M Exercise | 2025-12-26 | 2025-12-29 | 19,789 | $3.79 | $75.0K | 55,286 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | M Exercise deriv | 2025-11-25 | 2025-11-25 | 4,594 | — | $0 | 118,776 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | M Exercise deriv | 2025-11-25 | 2025-11-25 | 906 | — | $0 | 69,413 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | S Sale | 2025-11-25 | 2025-11-25 | 4,594 | $18.84 | $86.6K | 35,497 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | M Exercise | 2025-11-25 | 2025-11-25 | 4,594 | $3.79 | $17.4K | 40,091 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | S Sale | 2025-11-25 | 2025-11-25 | 906 | $18.84 | $17.1K | 35,497 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | M Exercise | 2025-11-25 | 2025-11-25 | 906 | $3.79 | $3.4K | 36,403 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | M Exercise deriv | 2025-11-24 | 2025-11-25 | 5,500 | — | $0 | 123,370 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | M Exercise | 2025-11-24 | 2025-11-25 | 5,500 | $3.79 | $20.8K | 40,997 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | S Sale | 2025-11-24 | 2025-11-25 | 5,500 | $18.45 | $101.5K | 35,497 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | M Exercise deriv | 2025-10-09 | 2025-10-10 | 22,000 | — | $0 | 128,870 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | S Sale | 2025-10-09 | 2025-10-10 | 22,000 | $18.45 | $405.9K | 35,497 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | M Exercise | 2025-10-09 | 2025-10-10 | 22,000 | $3.79 | $83.4K | 57,497 | SEC↗ |